Avalon GloboCare Corp (NASDAQ:ALBT) stock is trading lower on Wednesday. Apparently, there is no news to justify the movement.Avalon GloboCare, a company for precision diagnostic consumer products, on Tuesday announced the renewal of the U.S. Food and Drug Administration (FDA) establishment registration for its KetoAir device, a handheld breathalyzer designed for ketogenic health management.The device measures breath acetone concentration (BrAce), a key biomarker associated with fat metabolism and nutrition ...